University of York (Centre for Health Economics), York, UK.
United Nations University-International Institute for Global Health, Kuala Lumpur, Malaysia.
Global Health. 2019 Dec 18;15(1):86. doi: 10.1186/s12992-019-0513-7.
Addressing the social and other non-biological determinants of health largely depends on policies and programmes implemented outside the health sector. While there is growing evidence on the effectiveness of interventions that tackle these upstream determinants, the health sector does not typically prioritise them. From a health perspective, they may not be cost-effective because their non-health outcomes tend to be ignored. Non-health sectors may, in turn, undervalue interventions with important co-benefits for population health, given their focus on their own sectoral objectives. The societal value of win-win interventions with impacts on multiple development goals may, therefore, be under-valued and under-resourced, as a result of siloed resource allocation mechanisms. Pooling budgets across sectors could ensure the total multi-sectoral value of these interventions is captured, and sectors' shared goals are achieved more efficiently. Under such a co-financing approach, the cost of interventions with multi-sectoral outcomes would be shared by benefiting sectors, stimulating mutually beneficial cross-sectoral investments. Leveraging funding in other sectors could off-set flat-lining global development assistance for health and optimise public spending. Although there have been experiments with such cross-sectoral co-financing in several settings, there has been limited analysis to examine these models, their performance and their institutional feasibility.
This study aimed to identify and characterise cross-sectoral co-financing models, their operational modalities, effectiveness, and institutional enablers and barriers.
We conducted a systematic review of peer-reviewed and grey literature, following PRISMA guidelines. Studies were included if data was provided on interventions funded across two or more sectors, or multiple budgets. Extracted data were categorised and qualitatively coded.
Of 2751 publications screened, 81 cases of co-financing were identified. Most were from high-income countries (93%), but six innovative models were found in Uganda, Brazil, El Salvador, Mozambique, Zambia, and Kenya that also included non-public and international payers. The highest number of cases involved the health (93%), social care (64%) and education (22%) sectors. Co-financing models were most often implemented with the intention of integrating services across sectors for defined target populations, although models were also found aimed at health promotion activities outside the health sector and cross-sectoral financial rewards. Interventions were either implemented and governed by a single sector or delivered in an integrated manner with cross-sectoral accountability. Resource constraints and political relevance emerged as key enablers of co-financing, while lack of clarity around the roles of different sectoral players and the objectives of the pooling were found to be barriers to success. Although rigorous impact or economic evaluations were scarce, positive process measures were frequently reported with some evidence suggesting co-financing contributed to improved outcomes.
Co-financing remains in an exploratory phase, with diverse models having been implemented across sectors and settings. By incentivising intersectoral action on structural inequities and barriers to health interventions, such a novel financing mechanism could contribute to more effective engagement of non-health sectors; to efficiency gains in the financing of universal health coverage; and to simultaneously achieving health and other well-being related sustainable development goals.
解决健康的社会和其他非生物决定因素在很大程度上取决于卫生部门以外实施的政策和方案。虽然越来越多的证据表明,解决这些上游决定因素的干预措施是有效的,但卫生部门通常不会优先考虑这些措施。从健康角度来看,这些措施可能没有成本效益,因为它们的非健康结果往往被忽视。非卫生部门可能会低估对人口健康有重要共同效益的干预措施,因为它们专注于自己部门的目标。因此,具有多重发展目标影响的双赢干预措施的社会价值可能由于资源分配机制的分散而被低估和资源不足。在跨部门层面统筹预算可以确保这些干预措施的总体多部门价值得到体现,并更有效地实现各部门的共同目标。在这种共同融资方法下,具有多部门成果的干预措施的成本将由受益部门共同承担,从而刺激互利的跨部门投资。利用其他部门的资金可以抵消全球卫生发展援助的停滞不前,并优化公共支出。尽管在一些情况下已经进行了这种跨部门共同融资的实验,但对这些模式、其绩效和机构可行性进行的分析有限。
本研究旨在确定和描述跨部门共同融资模式、其运作方式、有效性以及机构的促成因素和障碍。
我们按照 PRISMA 指南对同行评议和灰色文献进行了系统回顾。如果提供了关于两个或多个部门或多个预算供资的干预措施的数据,则纳入研究。提取的数据进行了分类和定性编码。
在筛选出的 2751 篇文献中,有 81 个共同融资案例被确定。其中大多数来自高收入国家(93%),但在乌干达、巴西、萨尔瓦多、莫桑比克、赞比亚和肯尼亚发现了 6 个创新模式,其中还包括非公共和国际付款人。涉及的共同融资案例最多的是卫生(93%)、社会保健(64%)和教育(22%)部门。共同融资模式最常被用于为特定目标人群整合跨部门服务,尽管也发现一些模式旨在促进卫生部门以外的健康促进活动和跨部门的财务奖励。干预措施要么由单个部门实施和管理,要么以跨部门问责制的方式综合实施。资源限制和政治相关性是共同融资的关键促成因素,而不同部门参与者的角色和汇集目标不明确则被认为是成功的障碍。虽然严格的影响或经济评估很少,但经常报告积极的过程指标,有一些证据表明共同融资有助于改善结果。
共同融资仍处于探索阶段,不同的模式已在不同的部门和环境中实施。通过激励非卫生部门对结构性不平等和卫生干预措施的障碍采取跨部门行动,这种新的融资机制可以促进非卫生部门更有效地参与;提高全民健康覆盖的融资效率;并同时实现健康和其他与福祉相关的可持续发展目标。